Related Experiment Video
Updated: Jul 30, 2025
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
Published on: February 27, 2019
Chemical Strategies towards the Development of Effective Anticancer Peptides
1Key Laboratory of Chemical Biology (Ministry of Education), Department of Medicinal Chemistry, School of Pharmacy, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.
Abstract:
Cancer is increasingly recognized as one of the primary causes of death and has become a multifaceted global health issue. Modern medical science has made significant advancements in the diagnosis and therapy of cancer over the past decade. The detrimental side effects, lack of efficacy, and multidrug resistance of conventional cancer therapies have created an urgent need for novel anticancer therapeutics or treatments with low cytotoxicity and drug resistance. The pharmaceutical groups have recognized the crucial role that peptide therapeutic agents can play in addressing unsatisfied healthcare demands and how these become great supplements or even preferable alternatives to biological therapies and small molecules. Anticancer peptides, as a vibrant therapeutic strategy against various cancer cells, have demonstrated incredible anticancer potential due to high specificity and selectivity, low toxicity, and the ability to target the surface of traditional "undruggable" proteins. This review will provide the research progression of anticancer peptides, mainly focusing on the discovery and modifications along with the optimization and application of these peptides in clinical practice.
Insights
Anticancer peptides offer a promising new avenue for cancer treatment, showing high specificity and low toxicity. This review explores their discovery, modification, and clinical application as alternatives to conventional therapies.
Area of Science:
- Oncology and Pharmaceutical Sciences
- Biotechnology and Peptide Therapeutics
Background:
- Cancer is a leading global cause of death, with conventional therapies facing challenges like side effects, limited efficacy, and multidrug resistance.
- There is a critical need for novel anticancer treatments with reduced cytotoxicity and improved resistance profiles.
- Peptide therapeutics are emerging as significant alternatives or supplements to existing biological therapies and small molecules.
Purpose of the Study:
- To review the research progression of anticancer peptides (ACPs).
- To focus on the discovery, modification, optimization, and clinical application of ACPs.
- To highlight the potential of ACPs in addressing unmet healthcare needs in cancer therapy.
Main Methods:
- Literature review of scientific publications on anticancer peptides.
- Analysis of research trends in ACP discovery and development.
- Examination of modification strategies and optimization techniques for ACPs.
Main Results:
- Anticancer peptides demonstrate significant potential due to high specificity, selectivity, and low toxicity.
- ACPs can effectively target previously 'undruggable' proteins on cancer cell surfaces.
- The review details the evolution from discovery to clinical application of these peptide agents.
Conclusions:
- Anticancer peptides represent a vibrant and effective therapeutic strategy against diverse cancer types.
- Their unique properties make them valuable alternatives or complements to traditional cancer treatments.
- Further research and clinical application of ACPs are crucial for advancing cancer care.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...